Key result
The signaling helix domain (SHD) is obligatory for ANF/ATP-dependent signaling of ANF-RGC but has no role in its Ca2+/myristoylated neurocalcin delta-dependent activation.
Why the study?
Hormonal and Ca2+-modulated pathways of ANF-RGC operate via cyclic GMP through divergent operational modes, but how these two distinct transduction pathways segregate remained to be defined.
The study defines the molecular basis for the bimodal signal transduction of ANF-RGC, showing that the signaling helix domain segregates hormonal and Ca2+-modulated pathways.
SHD modulation of ANF-RGC remains preclinical; extends mapping of segregated hormonal versus Ca2+-dependent pathways.
Prototype member of the membrane guanylate cyclase family, ANF-RGC (Atrial Natriuretic Factor Receptor Guanylate Cyclase), is the physiological signal transducer of two most hypotensive hormones ANF and BNP, and of the intracellular free Ca2+. Both the hormonal and the Ca2+-modulated signals operate through a common second messenger, cyclic GMP; yet, their operational modes are divergent. The hormonal pathways originate at the extracellular domain of the guanylate cyclase; and through a cascade of structural changes in its successive domains activate its C-terminal catalytic domain (CCD). In contrast, the Ca2+-modulated pathway originates and is translated directly at the CCD via its sensor, myristoylated neurocalcin δ. Through a detailed sequential deletion and expression analyses, the present study demonstrates that segregation of the two transduction pathways occurs through the signaling helix domain (SHD). SHD is a conserved 35-amino acid helical region of the guanylate cyclase, composed of five heptads, each meant to tune and transmit the down-stream hormonal signals to the CCD for their translation and generation of cyclic GMP. Its structure is homo-dimeric with antiparallel configuration; it has no role in regulation of the Ca2+-modulated pathway. The findings establish and define in molecular terms the presence of two distinct non-overlapping transduction modes of ANF-RGC, and for the first time demonstrate how they operate, and, yet generate cyclic GMP utilizing common CCD machinery.
No takes yet. Share an insight, caveat, or question.
Duda et al. (2018) studied this question. SHD deletion and mutation in ANF-RGC vs. Wild-type ANF-RGC was evaluated on Guanylate cyclase catalytic activity. The signaling helix domain (SHD) is obligatory for ANF/ATP-dependent signaling of ANF-RGC but has no role in its Ca2+/myristoylated neurocalcin delta-dependent activation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: